PHARMAZZ, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2010-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.pharmazz.com
PMZ-1620 (Sovateltide) in Acute Ischemic Stroke Patients
Phase 2
Completed
- Conditions
- Acute StrokeCerebral Ischemia
- Interventions
- Drug: Normal Saline along with standard treatmentDrug: PMZ-1620 along with standard treatment
- First Posted Date
- 2019-08-06
- Last Posted Date
- 2025-05-12
- Lead Sponsor
- Pharmazz, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04046484
- Locations
- 🇮🇳
All India Institute of Medical Sciences, New Delhi, India
🇮🇳Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
🇮🇳Paras Hospital, Gurgaon, India
Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock
Phase 3
Completed
- Conditions
- Hypovolemic Shock
- Interventions
- Drug: Normal saline + Standard Treatment
- First Posted Date
- 2019-08-05
- Last Posted Date
- 2019-10-04
- Lead Sponsor
- Pharmazz, Inc.
- Target Recruit Count
- 105
- Registration Number
- NCT04045327
- Locations
- 🇮🇳
Seven Star Hospital, Nagpur, Maha, India
🇮🇳Radiant Superspeciality Hospital, Amravati, India
🇮🇳ACSR Government Medical College & Hospital, Nellore, India
A Study to Determine the Safety, Tolerability and Pharmacokinetics of PMZ-2010 (Centhaquin) in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: PMZ-2010 (Centhaquin)
- First Posted Date
- 2015-04-03
- Last Posted Date
- 2015-04-28
- Lead Sponsor
- Pharmazz, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT02408731
- Locations
- 🇮🇳
Jahangir Clinical Development Centre Pvt. Ltd., Pune, Maharastra, India
© Copyright 2025. All Rights Reserved by MedPath